Skip to content

Lactate Clearance After RIPC in Liver Resection

Lactate Clearance After Remote Ischaemic Preconditioning in Liver Resections

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05594641
Acronym
ARAGON
Enrollment
74
Registered
2022-10-26
Start date
2022-11-16
Completion date
2024-02-29
Last updated
2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Surgery, Remote Ischaemic Preconditioning

Keywords

lactate clearance, postoperative recovery

Brief summary

The primary aim of the study is the evaluation of the efficacy of remote ischemic preconditioning (RIPC) in terms of increase of the clearance of lactates 4 hours after the end of the hepatic resection. The secondary aims of the study are represented by the evaluation of the patients' postoperative recovery and the restoration of a normal lactate metabolism.

Detailed description

Hepatic surgery includes clamping of the hepatic peduncle (Pringle maneuver) to control intraoperative bleeding with a consequent reduction of postoperative complications. Surgical manipulations and Pringle maneuver, especially if prolonged and/or repeated, can cause ischemia-reperfusion damage. The technique of regional ischemic preconditioning was introduced to improve tolerance to ischemia. However, the scientific evidence currently does not support the routine use of regional ischemic preconditioning in hepatic surgery. It has recently been demonstrated that ischemic preconditioning can be effective when performed in the upper limb (RIPC). The main advantages of the remote ischaemic preconditiong compared to the regional one are the ease of use, the reduction of surgical time and hepatic ischemia. One of the most relevant epiphenomena of hepatic ischemia during hepatectomy is an increase in lactate levels in the immediate postoperative period that can be associated with an unfavorable outcome and can affect relevant clinical choices such as admission to intensive care. However, no previous studies have investigated the effectiveness of RIPC in improving lactate clearance after liver resection. The investigators hypothesized that applying RIPC before the start of the hepatic resection and the associated Pringle maneuvers could significantly increase lactate clearance 4 hours after the end of liver resection.

Interventions

A tourniquet will be applied to the right arm and it will be inflated (3 cycles, each lasting 5 minutes, at a pressure of 200 mmHg); each cycle is followed by 5 minutes of resting

OTHERControl

The tourniquet will be applied to the right arm but the cuff will be not inflated

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Elective liver surgey (laparotomic, laparoscopic and robotic-assisted) * Signed informed consent

Exclusion criteria

* Age \<18 years * Previous liver intervention including surgical and non surgical approach such as liver radiofrequency ablation and radiation therapy * Severe cardiopulmunary diseases * Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Lactate clearance4 hours after the end of liver resection(lactate at the end of liver resection minus lactate at 4 hours after the end of liver resection)\*100 to lactate at the end of liver resection

Secondary

MeasureTime frameDescription
Postoperative recoveryhours (RR) or days (ICU), and average of three hours for RR and one day in ICULenght of stay on recovery room (RR) or in intensive care (ICU)
In-hospital stayDays until discharge, an average of 7 daysHospital stay duration
Trend of lactate clearance1, 4 and 24 hours after the end of liver resectionRepeated measure for lactate clearance

Countries

Italy

Contacts

Primary ContactPaola Aceto, MD
paola.aceto@policlinicogemelli.it00390630154507
Backup ContactChiara Cambise, MD
chiara.cambise@policlinicogemelli.it00390630154507

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026